SpringWorks Therapeutics (SWTX)
(Delayed Data from NSDQ)
$37.41 USD
+1.49 (4.13%)
Updated Aug 9, 2024 03:59 PM ET
After-Market: $37.34 -0.07 (-0.19%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.88 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | 51.79% |
ABR | 1.00 |
Earnings ESP
|
13.26% |
---|---|
Current Year | -3.76 |
Next Year | -2.10 |
EPS (TTM) | -4.43 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 48.80M | 59.02M | 173.25M | 391.09M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 57.76M | 72.67M | 210.64M | 454.83M |
Low Estimate | 38.00M | 41.23M | 135.23M | 311.48M |
Year ago Sales | 0.00M | 5.45M | 5.45M | 173.25M |
Year over Year Growth Est. | NA | 982.94% | 3,080.61% | 125.74% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.88 | -0.82 | -3.76 | -2.10 |
# of Estimates | 5 | 5 | 6 | 6 |
Most Recent Consensus | -0.74 | -0.65 | -3.11 | 0.11 |
High Estimate | -0.60 | -0.50 | -2.83 | 0.11 |
Low Estimate | -1.12 | -1.14 | -4.52 | -3.33 |
Year ago EPS | -1.27 | -1.44 | -5.15 | -3.76 |
Year over Year Growth Est. | 30.71% | 43.06% | 26.99% | 44.02% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 3 | 2 | 4 | 3 |
Up Last 30 Days | 3 | 2 | 4 | 3 |
Up Last 60 Days | 3 | 2 | 4 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.88 | -0.82 | -3.76 | -2.10 |
7 Days Ago | -1.02 | -0.96 | -4.62 | -3.24 |
30 Days Ago | -1.02 | -0.96 | -4.62 | -3.24 |
60 Days Ago | -1.02 | -0.94 | -4.60 | -3.29 |
90 Days Ago | -1.02 | -0.94 | -4.60 | -3.29 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.76 | -0.58 | -3.47 | -2.11 |
Zacks Consensus Estimate | -0.88 | -0.82 | -3.76 | -2.10 |
Earnings ESP | 13.26% | 29.53% | 7.61% | -0.32% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | -1.18 | -1.44 | -1.27 | NA |
Estimate | -1.12 | -1.17 | -1.25 | -1.31 | NA |
Difference | 0.58 | -0.01 | -0.19 | 0.04 | 0.11 |
Surprise | 51.79% | -0.85% | -15.20% | 3.05% | 9.70% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more